Since Sept 1997 Dr Trevor Hansel has been Medical Director of the National Heart and Lung Institute (NHLI) Clinical Studies Unit of Imperial College, and an Honorary Consultant at the Royal Brompton Hospital in London.

Trevor obtained his medical degree in 1982 at the Welsh National School of Medicine, Cardiff and then completed higher specialist medical training in clinical immunology in Birmingham. From 1990-1993 he then performed clinical asthma research in Davos, Switzerland, developing methods for blood eosinophil isolation and sputum eosinophil surface marker assessment. Following this he worked in respiratory drug development with Sandoz and Roche in Basel; working in project management and clinical development.

Trevor has regulatory experience from the Biotechnology Unit of the Medicines Control Agency (MCA) in London. He has a specialist interest in phase II clinical testing of new anti-inflammatory therapies for asthma and COPD, involving bronchial and nasal challenge, and use of non-invasive biomarkers within blood and sputum. Trevor along with Peter Barnes authored “An Atlas of COPD” (Parthenon, 2004) and edited “New Drugs for Asthma, Allergy and COPD” (Karger, 2001).

Trevor is Deputy Editor of the Respiratory Medicine section of the Prous Science TTMed website, and is on the Editorial Board of Clinical and Experimental Allergy.